CalciMedica, Inc.

CalciMedica, Inc. ’s positive top-line Phase IIb data for Auxora (CM4620) in acute pancreatitis with accompanying systemic inflammatory response syndrome (SIRS) should position the calcium release-act

CG Oncology, Inc. achieved what no biopharmaceutical company has been able to do for more than two months – it went public in the US. The bladder cancer drug developer also launched the first initial

Hanmi, Celltrion Ink MPP Agreements For Molnupiravir Generics Hanmi Pharmaceutical Co., Ltd. has reached an agreement with the Medicines Patent Pool (MPP) to manufacture a generic version of Merck S

RedHill’s Opaganib Disappoints As RHB-107 Study Moves Forward A late-stage program by RedHill Biopharma Ltd. to develop a drug to treat patients hospitalized with severe COVID-19 pneumonia has fizzl